Most Recent
ANZ has lost its appeal of a landmark decision finding it breached continuous disclosure rules by failing to disclose a $750 million bailout by underwriters during a $2.5 billion capital raising.
Logistics giant Qube has won a $40 million cut to amounts owed to Martinus Rail in a dispute over construction of the Moorebank terminal project in Sydney's west.
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
A vaccine developer cannot prevent Flinders University from blocking his access to a research lab and interfering with the supply of mice for research relating to COVID-19 and other diseases.
Mills Oakley has lured three partners from rival firms to join its offices in Perth, Brisbane and Adelaide.
A class action by frustrated buyers over the $85 million sale of a Sydney development has failed to prevent the sale of lots, with a judge finding the class action's claims lack evidence.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
The ACCC will not oppose Lendlease’s plan to sell a portfolio of residential projects to Stockland for $1.3 billion after accepting Stockland’s plan to divest a project in Illawarra.
Vanguard Investments has been ordered to pay a penalty of almost $13 million for misleading the public about its $1 billion “ethically conscious” hedge fund.
Macquarie Bank has been fined a record $4.995 million for failing to stop the placement of suspicious orders on the electricity futures market.